CVR: 36184779
Secondary names: Meda ApS, Cross Pharma ApS, Medanica ApS
Previous names: BGP PRODUCTS ApS, Mylan Denmark ApS
DKK 329,091,791
Revenue
Net result: DKK 13,735,117
Meda AB
CVR · view ownership and management
Director role ended: Jan Ulrik Stevnsborg
CVR · 27/02/2026
View the full event history
Viatris ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Mylan Denmark ApS and BGP PRODUCTS ApS. The management consists of Lars Henrik Andreas Rejnus and Bente Brumoen. The company is owned by Meda AB. The company has 20 employees (2018). In 2025, the company reported revenue of DKK 329,091,791 and a net result of DKK 13,735,117 compared with DKK 17,942,708 the year before. Equity in the 2025 report amounted to DKK 170,575,865.
Source: annual report 2025, Danish Business Authority
Viatris ApS demonstrates a solid financial health with a consistent revenue generation trend, peaking at 467.4 million DKK in 2023, although it saw a decline to 329.1 million DKK in 2025. Profitability has remained relatively stable, with profits ranging from 11.1 million DKK in 2022 to 19.6 million DKK in 2023, indicating effective cost management despite fluctuating revenues. The company's equity has shown a positive trajectory, increasing from 108.2 million DKK in 2021 to 170.6 million DKK in 2025, reflecting a strengthening financial position. However, the decline in revenue in 2025 raises concerns about future growth prospects within the competitive pharmaceutical distribution industry.
AI-generated summary · Generated 28/06/2026
Selskabets formål er a. at importere, eksportere, købe, sælge, licensere, markedsføre, distribuere i eget navn og for egen regning eller som salgsrepræsentant eller salgskommissionær, farmaceutiske produkter, medicinaludstyr og lignende produkter og serviceydelser/tjenester, b. at fungere som holdingselskab for virksomheder, der importerer, eksporterer, køber, sælger, licenserer, markedsfører, distribuerer og vedligeholder farmaceutiske produkter, medicinaludstyr og lignende produkter og serviceydelser/tjenester, c. at stifte, deltage i, lede og have anden økonomisk interesse i andre selskaber og/eller virksomheder, d. at yde administrativ, saglig/faglig, finansiel, økonomisk, konsulent- eller ledelsesmæssige bistand til andre selskaber eller virksomheder, der er tilknyttet Selskabet, e. at erhverve, afstå, administrere og benytte/udnytte fast ejendom og løsøre, herunder patenter, varemærker, licenser, tilladelser og andre industrielle immaterielle rettigheder, f. at yde konsulentbistand og (midlertidig) virksomhedsrådgivning, g. at yde og udøve alle andre aktiviteter/handlinger som direkte og indirekte relaterer sig til ovennævnte, alt i begrebernes bredeste forstand inden for rammerne af den relevante lovgivning.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 329.1 mio. | 13.7 mio. | 200.3 mio. | 170.6 mio. | 33 | |
| 202401/01/2024 – 31/12/2024 | 447.8 mio. | 17.9 mio. | 277.7 mio. | 156.8 mio. | 35 | |
| 202301/01/2023 – 31/12/2023 | 467.4 mio. | 19.6 mio. | 240.4 mio. | 138.9 mio. | 35 | |
| 202201/01/2022 – 31/12/2022 | 439.7 mio. | 11.1 mio. | 358.8 mio. | 119.3 mio. | 41 | |
| 202101/01/2021 – 31/12/2021 | - | 18.1 mio. | 286.8 mio. | 108.2 mio. | 38 | |
| 202001/01/2020 – 31/12/2020 | - | 2.7 mio. | 273.4 mio. | 25.5 mio. | 31 | |
| 201901/01/2019 – 31/12/2019 | - | 5 mio. | 197.5 mio. | 22.9 mio. | 23 | |
| 201801/01/2018 – 31/12/2018 | - | 304 t. | 50.6 mio. | 17.9 mio. | 14 | |
| 201701/01/2017 – 31/12/2017 | - | 1.8 mio. | 22.9 mio. | 17.6 mio. | 4 | |
| 201601/01/2016 – 31/12/2016 | - | 1 mio. | 24.7 mio. | 15.7 mio. | 4 |
Compared to 407 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
30 public tenders won
Showing 10 of 30 contracts
See all won contracts on UdbudsScannerSources: TED (the EU tender database) and udbud.dk
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningViatris ApS was founded on 17 September 2014.
Viatris ApS is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler (industry code 464610).
Viatris ApS had 20 employees in 2018 according to the Danish CVR register.
Viatris ApS is owned by Meda AB.
In 2025, Viatris ApS reported revenue of DKK 329,091,791.
The management of Viatris ApS consists of Lars Henrik Andreas Rejnus and Bente Brumoen.
Claim this page to add your logo and social links. Free to get started.
Viatris ApS has published its annual report for 2025. Revenue came to DKK 329,091,791, and the net result was DKK 13,735,117.
Viatris ApS has won the tender "Amgros 2026 1.730.b" issued by Amgros I/S worth 499,581,045 DKK.
Contact info changed: new phone: 28116932 (March 9, 2026).
Contact info changed: new phone: 28116932 (February 28, 2026).
Contact info changed: new phone: 28116932 (February 27, 2026).
As of February 27, 2026, Lars Henrik Andreas Rejnus has joined the board of directors of Viatris ApS.
As of February 27, 2026, Jan Ulrik Stevnsborg has left the board of directors of Viatris ApS.
As of February 27, 2026, Lars Henrik Andreas Rejnus is registered as adm. dir. of Viatris ApS.
As of February 27, 2026, Jan Ulrik Stevnsborg has stepped down as director of Viatris ApS.
Viatris ApS has won the tender "Amgros 2026 1.170.b" issued by Amgros I/S worth 896,000,000 DKK.
Viatris ApS has won the tender "Amgros 2026 1.1454.b" issued by Amgros I/S worth 30,000,000 DKK.
Viatris ApS has won the tender "Amgros 2026 2.1305.a" issued by Amgros I/S worth 13,200,000 DKK.
Viatris ApS has won the tender "Amgros 2026 1.13.b" issued by Amgros I/S worth 21,304,703 DKK.
Viatris ApS has won the tender "Amgros 2026 1.842.b" issued by Amgros I/S worth 57,000,000 DKK.
Viatris ApS has won the tender "Amgros 2026 1.1452.a" issued by Amgros I/S worth 1,398,600,000 DKK.
Viatris ApS has won the tender "Amgros 2026 2.1303.b" issued by Amgros I/S worth 4,100,779 DKK.
Viatris ApS has won the tender "Amgros 2026 2.1390.b" issued by Amgros I/S worth 23,945,273 DKK.
Viatris ApS has won the tender "Amgros 2026 1.1205.b" issued by Amgros I/S worth 497,443,398 DKK.
Viatris ApS has won the tender "Amgros 2026 2.290.b" issued by Amgros I/S worth 88,050,546 DKK.
Viatris ApS has won the tender "Amgros 2026 2.1290.b" issued by Amgros I/S worth 13,286,794 DKK.
Viatris ApS has won the tender "Amgros 2026 2.690.b" issued by Amgros I/S worth 217,081,515 DKK.
Viatris ApS has won the tender "Amgros 2026 2.210.a" issued by Amgros I/S worth 102,909,186 DKK.
Viatris ApS has won the tender "Amgros 2026 1.604.a" issued by Amgros I/S worth 501,367,776 DKK.
Viatris ApS has won the tender "Amgros 2026 1.700.a" issued by Amgros I/S worth 245,033,539 DKK.
Viatris ApS has won the tender "Amgros 2026 1.810.a" issued by Amgros I/S worth 137,104,621 DKK.
Viatris ApS has published its annual report for 2024. Revenue came to DKK 447,760,640, and the net result was DKK 17,942,708.
Viatris ApS has won the tender "Amgros 2025 1.873.a" issued by Amgros I/S worth 244,500,000 DKK.
Viatris ApS has won the tender "Amgros 2025 1.161.b" issued by Amgros I/S worth 472,500,000 DKK.
Viatris ApS has won the tender "Udbud af rammeaftale om influenzavaccine" issued by Statens Serum Institut worth 1 DKK.
Viatris ApS has won the tender "Amgros 2025 1.958.b" issued by Amgros I/S worth 326,700,000 DKK.
Viatris ApS has won the tender "Amgros 2025 1.1211.b" issued by Amgros I/S worth 14,600,000 DKK.
Viatris ApS has won the tender "Amgros 2025 1.205.a" issued by Amgros I/S worth 37,203,010 DKK.
Viatris ApS has won the tender "Amgros 2025 1.791.b" issued by Amgros I/S worth 7,090,202 DKK.
Viatris ApS has won the tender "Amgros 2025 1.13.b" issued by Amgros I/S worth 20,100,000 DKK.
Viatris ApS has won the tender "Amgros 2025 2.3.b" issued by Amgros I/S worth 359,770,187 DKK.
Viatris ApS has won the tender "Amgros 2025 1.290.b" issued by Amgros I/S worth 4,463,413 DKK.
Viatris ApS has won the tender "Amgros 2025 1.550.b" issued by Amgros I/S worth 652,620,000 DKK.
As of September 12, 2024, Bente Brumoen is registered as director of Viatris ApS.
Viatris ApS has published its annual report for 2023. Revenue came to DKK 467,397,712, and the net result was DKK 19,602,786.
Viatris ApS has won the tender "Amgros 2024 1.1450.a" issued by Amgros I/S worth 1,003,800,000 DKK.
Viatris ApS has won the tender "Amgros 2024 1.472.a" issued by Amgros I/S worth 20,675,200,000 DKK.
Viatris ApS has published its annual report for 2022. Revenue came to DKK 439,661,647, and the net result was DKK 11,107,406.
As of April 24, 2023, Bente Brumoen has joined the board of directors of Viatris ApS.
As of April 24, 2023, Arun Narayan has joined the board of directors of Viatris ApS.
As of April 24, 2023, Kurt Glud has left the board of directors of Viatris ApS.
As of April 24, 2023, Luis Rodolfo Birbuet has left the board of directors of Viatris ApS.
Viatris ApS has published its annual report for 2021. Gross profit came to DKK 60,733,547, and the net result was DKK 18,078,563.
On September 1, 2021, the company changed its name from Mylan Denmark ApS to Viatris ApS.
As of July 14, 2021, is registered as an owner of Viatris ApS with an ownership share of 100%.
Viatris ApS has published its annual report for 2020. Gross profit came to DKK 38,063,214, and the net result was DKK 2,657,842.
As of February 19, 2021, Luis Rodolfo Birbuet has joined the board of directors of Viatris ApS.
As of February 19, 2021, Jose Javier Cotarelo has left the board of directors of Viatris ApS.
Viatris ApS has published its annual report for 2019. Gross profit came to DKK 30,329,017, and the net result was DKK 4,977,953.
On July 1, 2019, the company changed its name from BGP PRODUCTS ApS to Mylan Denmark ApS.
Viatris ApS has published its annual report for 2018. Gross profit came to DKK 16,870,856, and the net result was DKK 304,064.
As of November 20, 2018, Jose Javier Cotarelo has joined the board of directors of Viatris ApS.
As of November 20, 2018, Anthonius Matthijs van 't Hullenaar has left the board of directors of Viatris ApS.
As of July 18, 2018, Kurt Glud has joined the board of directors of Viatris ApS.
As of July 18, 2018, Gitte Jürgens has left the board of directors of Viatris ApS.
As of July 18, 2018, Vidar Sie has stepped down as director of Viatris ApS.
Viatris ApS has published its annual report for 2017. Gross profit came to DKK 12,745,740, and the net result was DKK 1,844,122.
As of September 5, 2017, Anthonius Matthijs van 't Hullenaar has joined the board of directors of Viatris ApS.
As of September 5, 2017, Jean-Yves Brault has left the board of directors of Viatris ApS.
Viatris ApS has published its annual report for 2016. Gross profit came to DKK 10,365,686, and the net result was DKK 1,043,586.
As of June 16, 2017, Gitte Jürgens has joined the board of directors of Viatris ApS.
As of June 16, 2017, Olof Frykman has left the board of directors of Viatris ApS.
As of November 7, 2016, Jan Ulrik Stevnsborg has joined the board of directors of Viatris ApS.
As of October 7, 2016, Olof Frykman has joined the board of directors of Viatris ApS.
As of October 7, 2016, Jean-Yves Brault has joined the board of directors of Viatris ApS.
As of October 7, 2016, Sandeep Puri has left the board of directors of Viatris ApS.
As of October 7, 2016, Jean-Yves Brault has left the board of directors of Viatris ApS.
As of October 7, 2016, Jan Ulrik Stevnsborg is registered as director of Viatris ApS.
As of July 4, 2016, Palle Michael Christensen has left the board of directors of Viatris ApS.
As of July 4, 2016, Palle Michael Christensen has stepped down as director of Viatris ApS.
Viatris ApS has published its interim report for the period September 17, 2014 – December 31, 2015.
As of January 28, 2016, Jean-Yves Brault has joined the board of directors of Viatris ApS.
As of January 28, 2016, Jacek Glinka has left the board of directors of Viatris ApS.
As of September 2, 2015, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Viatris ApS.
As of September 2, 2015, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Viatris ApS.
As of July 16, 2015, Vidar Sie is registered as director of Viatris ApS.
As of February 27, 2015, Sandeep Puri has joined the board of directors of Viatris ApS.
As of February 27, 2015, Jacek Glinka has joined the board of directors of Viatris ApS.
As of February 27, 2015, Thomas Craig Freyman has left the board of directors of Viatris ApS.
As of February 27, 2015, Björn Fredrik Anders Björnulfson has left the board of directors of Viatris ApS.
As of September 17, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of Viatris ApS.
As of September 17, 2014, Palle Michael Christensen has joined the board of directors of Viatris ApS.
As of September 17, 2014, Thomas Craig Freyman has joined the board of directors of Viatris ApS.
As of September 17, 2014, Björn Fredrik Anders Björnulfson has joined the board of directors of Viatris ApS.
As of September 17, 2014, Palle Michael Christensen is registered as director of Viatris ApS.
Viatris ApS was founded on September 17, 2014.
Companies in the same industry and area
CVR 35435778
CVR 28714084
CVR 38163566
CVR 66351912
CVR 39640163
